REN PINGDA has a total of 22 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are INTELLIKINE LLC, BEIJING SCITECH MQ PHARMACEUTICALS LTD and VERNALIS (R&D) LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | China | 1 | |
#3 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Medical technology | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Ren Pingda | 22 |
#2 | Liu Yi | 18 |
#3 | Wilson Troy Edward | 17 |
#4 | Li Liansheng | 16 |
#5 | Chan Katrina | 15 |
#6 | Rommel Christian | 5 |
#7 | Martin Michael | 4 |
#8 | Campbell Simon Fraser | 3 |
#9 | Isbester Paul | 3 |
#10 | Kropp Jason | 3 |
Publication | Filing date | Title |
---|---|---|
US2015158859A1 | Heterocyclic compounds and uses thereof | |
WO2012097000A1 | Processes for preparing isoquinolinones and solid forms of isoquinolinones | |
US2010184760A1 | Benzoxazole kinase inhibitors and methods of use | |
US2009312319A1 | Substituted isoquinolin-1(2H)-ones, and methods of use thereof | |
US2011172228A1 | Kinase inhibitors and methods of use | |
US2011124641A1 | Benzothiazole kinase inhibitors and methods of use | |
US2011160232A1 | Certain chemical entities and therapeutic uses thereof |